Patents by Inventor Yi-Chi Su

Yi-Chi Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250043176
    Abstract: An organic electroluminescent material is used for a sensitizer layer of an organic light-emitting diode. The organic electroluminescent material includes a structure of the following General Formula (1): A is selected from the group consisting of General Formula (2), a carbazole group, and a substituted benzimidazole group. The present invention also discloses an organic light-emitting diode which has a sensitizer layer. The sensitizer layer includes a structure of General Formula (1).
    Type: Application
    Filed: August 2, 2024
    Publication date: February 6, 2025
    Inventors: Tien-Lung CHIU, Man-Kit LEUNG, Chia-Hsun CHEN, Chen-Jun CHU, Chi-Chi CHANG, Yi-Ru HAUNG, Jiun-Haw LEE, Lian-Chun HUANG, Zi-Wen SU, Yuan-Zhen ZUANG, Jing-Xiang HUANG
  • Publication number: 20120064066
    Abstract: The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
    Type: Application
    Filed: June 14, 2011
    Publication date: March 15, 2012
    Applicant: Galaxy Biotech, LLC
    Inventors: Kyung Jin Kim, Yi-Chi Su
  • Patent number: 7687063
    Abstract: The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: March 30, 2010
    Assignee: Galaxy Biotech, LLC
    Inventors: Kyung Jin Kim, Yi-Chi Su
  • Publication number: 20090104192
    Abstract: The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
    Type: Application
    Filed: December 22, 2008
    Publication date: April 23, 2009
    Applicant: Galaxy Biotech, LLC
    Inventors: Kyung Jin Kim, Yi-Chi Su
  • Patent number: 7494650
    Abstract: The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
    Type: Grant
    Filed: February 23, 2007
    Date of Patent: February 24, 2009
    Assignee: Galaxy Biotech, LLC
    Inventors: Kyung Jin Kim, Yi-Chi Su
  • Publication number: 20080019966
    Abstract: The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
    Type: Application
    Filed: June 13, 2007
    Publication date: January 24, 2008
    Applicant: Galaxy Biotech, LLC
    Inventors: Kyung Kim, Yi-Chi Su, Lihong Wang
  • Publication number: 20070160613
    Abstract: The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
    Type: Application
    Filed: February 23, 2007
    Publication date: July 12, 2007
    Applicant: Galaxy Biotech, LLC
    Inventors: Kyung Kim, Yi-Chi Su, Lihong Wang
  • Patent number: 7220410
    Abstract: The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: May 22, 2007
    Assignee: Galaxy Biotech, LLC
    Inventors: Kyung Jin Kim, Yi-Chi Su
  • Publication number: 20050019327
    Abstract: The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
    Type: Application
    Filed: August 13, 2004
    Publication date: January 27, 2005
    Inventors: Kyung Kim, Yi-Chi Su, Lihong Wang
  • Publication number: 20040208876
    Abstract: The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
    Type: Application
    Filed: April 15, 2004
    Publication date: October 21, 2004
    Inventors: Kyung Jin Kim, Yi-Chi Su, Lihong Wang